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Abstract 
Formation constants of transition metal complexes with Adenosine biomolecule, Glutamic acid, and isoleucine 
amino acids have been studied pH metrically in 20% v/v ethyl alcohol and water medium at 30°C temperature 
and 0.1 M ionic strength. The proton ligand stability constant (pKa) of ligands and metal ligand stability 
constant (logK) of binary metal complexes were determined. It is correlated with atomic numbers, basicity of 
ligands, and atomic radii of metal ions. The transition metal complexes of ligands follow the Irving William 
natural order of stability.    
Keywords: Formation Constants, Metal Complexes, Adenosine, Amino Acids. 
Introduction 
The formation of metal complexes depends on metal ligand selectivity in complex media. The formation 
constant of metal complexes with biomolecule and amino acids are important to measure the metal ligand 
selectivity and strength of metal ligand bonds ( Thomas,2002). The metal complexes of drug are found more 
potent than drugs (Sarkar,1999). It plays a vital role in metabolism, transportation, detoxification and catalytic 
process. The knowledge of metal complexes with drugs is essential to understand proper dose of drug. In 
addition, it helps to know the complex physiological process and mode of action of drugs and their effect on 
various body systems. The literature survey reveals that there is still need to study the binary complexes of 
transition metal ions with drugs and amino acids to know the coordination behavior (Deore et. al, 2011; 
Gandhi and Sekhon., 2006;Magare and Ubale,2011;Magare and Ubale,2018;Magare,2019;Phase et al 
,2013;Sakhare et al,2019)  
Adenosine (Fig.1.0) being a purine nucleoside performs many important functions in human body and 
biological processes (Cummings,1994). It modulates physiological function in heart and brain, regulates 
oxygen supply during cell stress and play an important role in the regulation of renal function 
(Kloor,2000;Zhang,1997). It is a potent anti-inflammatory and anti-arrhythmic agent which is important for the 
control of coronary and cerebral blood flow (Phillis,2004; Tesch,2004). It is an inhibitory neurotransmitter 
(Gruber,1991; Nishiyama et al,2004) and play a role in promoting sleep and suppressing arousal (Bashir et 
al,2000). Adenosine is an endogenous vasodilation agent (Martin et al,2000) and also administered for the 
treatment of gastrointestinal diseases in many cases (Ye and Rajendran,2009). The amounts of Adenosine in 
the urine and plasma samples are considered be marker of some diseases such as carcinoma or liver diseases 
(Yang et al,2002).  
 Glutamic acid (Meister,1965) (Fig. 2.0) is acidic non-essential glycogenic amino acid with one amino 
group and two carboxylic groups. It takes part in transamination, transamidation and inter conversion of 
amino acids and also participate in ammonia transport and urea formation. Glutamic acid involve in 
To Chemistry Journal Vol 6 (2020) ISSN: 2581-7507                                                       http://purkh.com/index.php/tochem 
 110 
glycogenic function, on deamination it form oxaloacetate and α-ketoglutarate and form glycogen. Its wide 
range contribution in urea formation, purine, and pyrimidine rings synthesis. Glutamic acid on decarboxylation 
gives rise to gamma aminobutyric acid. It controls the neuronal activity. Glutamic acid is one of the constituent 
of glutathione which is important in the activity of sulphadryl enzyme system. Studies over the last several 
years have explored the physiological role and therapeutic utility of these molecules in various diseases 
conditions (Colquhonn and Newsholme,1997;Pitha et al 1980).  Recently Satyajit Datta et al. have reported 
glutamic acid analogues used as potent anticancer (Kato et al,1984). 
 Isoleucine (Fig. 3.0) is an essential amino acid, which means that human cannot synthesize it, so it 
must be part of our diet. It promotes muscles recovery, needed for the formation of haemoglobin regulation 
of blood sugar level and blood clot formation. Deficiency of isoleucine is only found in people deficient in 
dietary protein but symptoms may include headache, dizziness, fatigue, depression & confusion. Isoleucine 
has also several significant applications in biological systems (Li et al,2009; Mitrophanov,2008;Papp et al 2010) 
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Hence formation constants of Co (II), Ni (II) Cu (II) and Zn (II) transition metal ion complexes with biomolecule 
nucleoside, glutamic acid and isoleucine amino acids were carried out in 20% v/v alcohol water media. 
Chemicals and Methods 
The solution of ligands were prepared in pure alcohol. The other solutions were prepared in double glass 
distilled water having pH 6.70-6.90. The chemicals used for present study were of A.R. grade. The alcohol was 
purified by standard procedure. The concentrations of solutions were determined by standard procedures 
(Bates,1973;Vogel,1975). The determination of stability constants of binary complexes were involved three 
steps. 
1) Free acid (A) 
2) Free acid + Ligand (A+L) 
3) Free acid + Ligand + Metal (A+L+ M) 
These three sets were titrated separately with standard sodium hydroxide solution at 300C temperature in 20% 
v/v alcohol water solution pH metrically by using Irving Rossotti titration technique (Irving and Rossoti,1953). 
The 0.1M ionic strength of each solution was maintained constant by addition of NaClO4. Initial volume of 
solution was kept 50 ml constant by adding requisite amount of distilled water and pure alcohol. 
Results and Discussion 
Proton ligand stability constant (pKa)  
The pKa values of Adenosine and amino acids were determined by point wise and half integral methods. 
Adenosine shows only one pKa (3.44) due to (-OH) group. It is a weak acidic group due to powerful electron 
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withdrawing effect. The observed pKa values of amino acids show little deviation with literature values due to 
different medium and environmental conditions. 
TABLE: 1.0 STABILITY CONSTANT OF METAL IONS WITH BIOMOLECULE AND AMINO ACIDS. 
Medium: - 20% (v/v) Ethanol-Water mixture   Temp = 30°C          = 0.1 M NaClO4 
Ligand 
 
pK1 pK2 
Cu (II) Zn (II) Ni (II) Co (II) 
Log 
K1 
Log 
K2 
Log 
β 
Log 
K1 
Log 
K2 
Log 
β 
Log 
K1 
Log 
K2 
Log 
Β 
Log 
K1 
Log 
K2 
Log 
β 
Adenosine 
( L1 ) 
3.44 ---- 5.07 4.33 9.40 4.32 3.88 8.20 3.56 3.25 6.81 3.43 3.27 6.70 
Glutamic 
acid ( L2 ) 
2.59 4.99 10.29 8.33 18.62 5.10 4.29 9.39 7.77 5.99 13.76 5.57 4.52 10.09 
Iso 
leucine 
( L3 ) 
2.53 9.72 9.54 6.69 16.23 4.28 3.44 7.72 5.01 3.75 8.76 3.95 3.03 6.98 
 
The glutamic acid and isoleucine show two pKa values. The values of n‾A are indicates the presence of pK1 and 
pK2. The values observed in the present study were in good agreement with literature values (Table 1.0). The 
slight deviation observed may be due to the difference in experimental conditions like temperature, ionic 
strength, techniques, and medium used. 
Metal ligand stability constants ( LogK ) 
The displacement of metal titration curves with respect to ligand titration curve along volume axis indicates 
the formation of complex species. The LogK values were determined by pointwise calculation method as well 
as half integral method. The pKa, LogK and logβ values were enlisted in Table 1.0. 
The values of n‾ of Adenosine, glutamic acid and isoleucine are shows the formation of 1:1 and 1:2 complexes. 
The transition metal complexes of ligand L1 show low stability than L2 and L3 ligands. It may be attributed to 
monodentate and bidentate nature and different basicity of ligands. 
The order of stability of transition metal ions complexes with L1 ligand and amino acids L2 and L3 in the present 
study are as follows: 
Adenosine L1: Co (II) < Ni (II) < Cu (II) >Zn (II) 
Glutamic acid L2: Co (II) < Ni (II) < Cu (II) >Zn (II) 
Isoleucine L3: Co (II) < Ni (II) < Cu (II) >Zn (II) 
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The plots of LogK versus atomic number, atomic radii were plotted and it is observed that the complexes of L1, 
L2 and L3 ligands follow the Irving William natural order of stability (Irving and William,1946). The low values of 
LogK in L1 drug indicates ionic interactions whereas high LogK values of L2 and L3 ligands may be attributed to 
covalent interactions (Rajbhoj et al,2007;Rao et al,2006). 
Conclusion 
The complexes of L1, L2 and L3 ligands follow the Irving William natural order of stability.  The low values of 
LogK in L1 drug indicates ionic interactions whereas high LogK values of L2 and L3 ligands may be attributed to 
covalent interactions.  
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